March 26, 2026 at 11:47PM FDA Approves First Gene Therapy for Severe Leukocyte Adhesion Deficiency Type I

The U.S. Food and Drug Administration today approved Kresladi (marnetegragene autotemcel), the first gene therapy for the treatment of severe Leukocyte Adhesion Deficiency Type I (LAD-I).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/P6gHXdE